JP2014533282A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533282A5
JP2014533282A5 JP2014541358A JP2014541358A JP2014533282A5 JP 2014533282 A5 JP2014533282 A5 JP 2014533282A5 JP 2014541358 A JP2014541358 A JP 2014541358A JP 2014541358 A JP2014541358 A JP 2014541358A JP 2014533282 A5 JP2014533282 A5 JP 2014533282A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
urea
dioxoimidazolidin
bromophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541358A
Other languages
English (en)
Japanese (ja)
Other versions
JP6078075B2 (ja
JP2014533282A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/064571 external-priority patent/WO2013071203A1/en
Publication of JP2014533282A publication Critical patent/JP2014533282A/ja
Publication of JP2014533282A5 publication Critical patent/JP2014533282A5/ja
Application granted granted Critical
Publication of JP6078075B2 publication Critical patent/JP6078075B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541358A 2011-11-10 2012-11-10 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体 Expired - Fee Related JP6078075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161558080P 2011-11-10 2011-11-10
US61/558,080 2011-11-10
PCT/US2012/064571 WO2013071203A1 (en) 2011-11-10 2012-11-10 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017004062A Division JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Publications (3)

Publication Number Publication Date
JP2014533282A JP2014533282A (ja) 2014-12-11
JP2014533282A5 true JP2014533282A5 (enExample) 2017-01-05
JP6078075B2 JP6078075B2 (ja) 2017-02-08

Family

ID=47222328

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014541358A Expired - Fee Related JP6078075B2 (ja) 2011-11-10 2012-11-10 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体
JP2017004062A Expired - Fee Related JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017004062A Expired - Fee Related JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Country Status (13)

Country Link
US (1) US8492556B2 (enExample)
EP (2) EP2776403B1 (enExample)
JP (2) JP6078075B2 (enExample)
KR (1) KR102271500B1 (enExample)
CN (1) CN104114541A (enExample)
AU (2) AU2012335039C1 (enExample)
BR (1) BR112014011316A2 (enExample)
CA (1) CA2855390C (enExample)
DK (1) DK3103797T3 (enExample)
ES (1) ES2733826T3 (enExample)
RU (1) RU2645673C2 (enExample)
TR (1) TR201909663T4 (enExample)
WO (1) WO2013071203A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2770989T (pt) 2011-10-26 2018-12-04 Allergan Inc Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1)
US8492556B2 (en) * 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
CA2899804A1 (en) * 2013-03-06 2014-09-12 Allergan, Inc. Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
RU2663911C2 (ru) * 2013-03-06 2018-08-13 Аллерган, Инк. Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз
AR097279A1 (es) 2013-08-09 2016-03-02 Actelion Pharmaceuticals Ltd Derivados de benzimidazolil-metil urea como agonistas del receptor de alx
AU2014352922B2 (en) 2013-11-21 2018-06-07 Allergan, Inc. Phenylcarbamate derivatives as formyl peptide receptor modulators
NZ752095A (en) * 2013-11-28 2022-07-01 Kyorin Seiyaku Kk Urea derivative or pharmacologically acceptable salt thereof
US9604934B2 (en) 2014-01-29 2017-03-28 Allergan, Inc. Urea hydantoin derivatives as formyl peptide modulators
US9920013B2 (en) * 2014-01-29 2018-03-20 Allergan, Inc. 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
US10301269B2 (en) * 2014-05-21 2019-05-28 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators
WO2016094846A1 (en) 2014-12-11 2016-06-16 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods
US10525058B2 (en) * 2015-05-27 2020-01-07 Kyorin Pharmaceutical Co., Ltd Urea derivative or pharmacologically acceptable salt thereof
US10858314B2 (en) 2015-05-27 2020-12-08 Kyorin Pharmaceutical Co., Ltd. Urea derivative or pharmacologically acceptable salt thereof
JP2020015664A (ja) * 2016-11-21 2020-01-30 宇部興産株式会社 含窒素多環式ヘテロ環誘導体
EP3634958B1 (en) * 2017-06-09 2021-07-21 Bristol-Myers Squibb Company Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
SG11202008504SA (en) * 2018-03-05 2020-10-29 Bristol Myers Squibb Co Phenylpyrrolidinone formyl peptide 2 receptor agonists
KR102217512B1 (ko) * 2020-07-07 2021-02-19 한화시스템 주식회사 배터리 관리 시스템을 통한 회수 요청 또는 자동 복귀를 수행하는 무인 잠수정
CN114805334B (zh) * 2022-05-24 2023-06-09 深圳大学 一种QC和GSK-3β多靶向抑制剂及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1284973T3 (da) * 2000-05-31 2007-10-08 Tanabe Seiyaku Co Inhibitorer af alfaLbeta2-medieret celleadhæsion
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
WO2003006424A1 (en) * 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
FR2850652B1 (fr) * 2003-01-31 2008-05-30 Aventis Pharma Sa Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
CN1894580A (zh) * 2003-11-07 2007-01-10 阿卡蒂亚药品公司 脂氧素受体fprl1作为一种用于鉴定能有效治疗疼痛和炎症化合物的工具
WO2005087236A1 (en) * 2004-03-11 2005-09-22 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
US20080004282A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2009064431A1 (en) * 2007-11-15 2009-05-22 Eisai E & D Management Co., Ltd. Methods of use
US8541577B2 (en) * 2011-11-10 2013-09-24 Allergan, Inc. Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
US8492556B2 (en) * 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
CA2864893A1 (en) * 2012-02-16 2013-08-22 Allergan, Inc. Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators

Similar Documents

Publication Publication Date Title
RU2014122753A (ru) Производные 2,5-диоксоимидазолидин-1-ил-3-фенилмочевины в качестве модуляторов формилпептидного рецептора 1 (fprl-1)
JP2016512194A5 (enExample)
RU2424233C2 (ru) Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
Gaba et al. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
AR106735A1 (es) Composiciones y métodos insecticidas
JP2012525431A5 (enExample)
ME00044B (me) Substituisani imidazoli i njihova upotreba kao pesticida
RU2015136774A (ru) Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
RU2015134778A (ru) Применение агонистов формилпептидного рецептора 2 для лечения дерматологических заболеваний
RU2005111225A (ru) Производные триазаспиро[5.5]ундекана и лекарственные средства, содержащие их в качестве активного ингредиента
FI3625233T5 (fi) 3-(((((2s,5r)-2-karbamoyyli-7-okso-1,6-diatsabisyklo[3.2.1]oktan-6-yyli)oksi)sulfonyyli)oksi)-2,2-dimetyylipropanoaattijohdannaisia ja niihin liittyviä yhdisteitä beetalaktamaasiestäjien suun kautta otettavina aihiolääkkeinä bakteeri-infektioiden hoitamiseksi
JP2014516360A5 (enExample)
JP2013507425A5 (enExample)
RU2013151174A (ru) Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
RU2011121665A (ru) Производные 7-гидроксибензимидазол-4-илметанона и содержащие их ингибиторы рвк
HRP20130738T1 (hr) Postupak lijeäśenja ili profilakse
FR2741342A1 (fr) Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
RU2014111980A (ru) Сшиваемая композиция, способная к сшиванию по реакции присоединения михаэля (rma)
EA031030B1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
EP1261601A1 (de) Substituierte indole zur modulierung von nfkb-aktivität
RU2503663C2 (ru) Мостиковые шестичленные циклические соединения
HRP20100114T1 (hr) Derivati azabiciklo[3.1.0]heksana korisni kao modulatori dopaminskih receptora d3
JP2015535834A5 (enExample)
JP2012507525A5 (enExample)